Pro Share Advisors LLC Zai Lab LTD Transaction History

Pro Share Advisors LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$34.2 - $51.69 $200,241 - $302,644	5,855 New	5,855 $200,000
Q2 2022 Aug 01, 2022	SELL	$23.14 - $49.68 $169,199 - $363,260	-7,312 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$27.77 - $64.4 $71,396 - $165,572	-2,571 Reduced 26.01%	7,312 $322,000
Q4 2021 Feb 08, 2022	SELL	$54.9 - $105.21 $270,876 - $519,106	-4,934 Reduced 33.3%	9,883 $621,000
Q3 2021 Nov 12, 2021	BUY	$105.0 - $178.37 $397,530 - $675,308	3,786 Added 34.32%	14,817 $1.56 Million
Q2 2021 Aug 13, 2021	BUY	$125.11 - $180.0 $346,679 - $498,780	2,771 Added 33.55%	11,031 $1.95 Million
Q1 2021 May 14, 2021	SELL	$126.27 - $191.71 $42,426 - $64,414	-336 Reduced 3.91%	8,260 $1.1 Million
Q4 2020 Feb 09, 2021	SELL	$81.94 - $135.34 $23,025 - $38,030	-281 Reduced 3.17%	8,596 $1.16 Million
Q3 2020 Nov 13, 2020	BUY	$73.3 - $89.48 $23,089 - $28,186	315 Added 3.68%	8,877 $738,000
Q2 2020 Aug 03, 2020	BUY	$48.82 - $82.53 $167,843 - $283,738	3,438 Added 67.1%	8,562 $703,000
Q1 2020 May 15, 2020	SELL	$39.1 - $62.9 $113,976 - $183,353	-2,915 Reduced 36.26%	5,124 $264,000
Q4 2019 Feb 12, 2020	SELL	$29.79 - $43.06 $41,676 - $60,240	-1,399 Reduced 14.82%	8,039 $334,000
Q3 2019 Nov 12, 2019	BUY	$30.47 - $37.65 $95,919 - $118,522	3,148 Added 50.05%	9,438 $305,000
Q2 2019 Aug 13, 2019	SELL	$25.73 - $35.79 $19,812 - $27,558	-770 Reduced 10.91%	6,290 $219,000
Q1 2019 May 15, 2019	BUY	$21.71 - $31.54 $153,272 - $222,672	7,060 New	7,060 $208,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.75B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.